Bellevue Funds (Lux) - Bellevue Healthcare Strategy I2 Fonds
187,01
CHF
+1,48
CHF
+0,80
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Thermo Fisher Scientific Inc | US8835561023 | 3,57% |
| Galderma Group AG Registered Shares | CH1335392721 | 3,41% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,21% |
| AbbVie Inc | US00287Y1091 | 3,18% |
| Sandoz Group AG Registered Shares | CH1243598427 | 3,10% |
| UCB SA | BE0003739530 | 3,07% |
| Abbott Laboratories | US0028241000 | 3,01% |
| Eli Lilly and Co | US5324571083 | 3,01% |
| Boston Scientific Corp | US1011371077 | 2,97% |
| Stryker Corp | US8636671013 | 2,96% |
| Sonstige | 68,50% |